Literature DB >> 9353030

A novel component different from endotoxin extracted from Prevotella intermedia ATCC 25611 activates lymphoid cells from C3H/HeJ mice and gingival fibroblasts from humans.

K Iki1, K Kawahara, S Sawamura, R Arakaki, T Sakuta, A Sugiyama, H Tamura, T Sueda, S Hamada, H Takada.   

Abstract

A novel immunobiologically active fraction was prepared from a phenol-water extract of Prevotella intermedia ATCC 25611 by Sephadex G-100 column chromatography. The fraction consisted mainly of carbohydrate and protein and was devoid of fatty acid. The fraction showed high-molecular-weight bands (10,000 to 12,000) on deoxycholate polyacrylamide gel electrophoresis (DOC-PAGE) and was scarcely active in a Limulus test. We designated the fraction Prevotella glycoprotein (PGP). The PGP fraction showed strong mitogenicity on splenocytes and cytokine-inducing activities on peritoneal macrophages from both C3H/HeJ and C3H/HeN mice, and it stimulated human gingival fibroblasts to produce cytokines. The activities of the PGP fraction were resistant to heat inactivation (100 degrees C for 1 h) and protease treatments and were scarcely inhibited by polymyxin B. In contrast, the purified lipopolysaccharide fraction (LPS-PCP) extracted from the same bacterium with a phenol-chloroform-petroleum ether mixture, which showed strong Limulus activity and a single low-molecular-weight band (approximately 3,000) on DOC-PAGE, lacked the activities on splenocytes and macrophages from C3H/HeJ mice and human gingival fibroblasts. The activities of the LPS-PCP fraction on cells from C3H/HeN mice were completely inhibited by polymyxin B. The LPS extracted from the same bacterium with hot phenol-water (LPS-PW) exhibited the properties of both the PGP fraction and the LPS-PCP fraction. These findings suggest that the unique bioactivities of the LPS-PW fraction of oral black-pigmented bacteria reported to date, which differed from those of the classical endotoxin, were derived from the PGP fraction and not from the LPS itself.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9353030      PMCID: PMC175651          DOI: 10.1128/iai.65.11.4531-4538.1997

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  43 in total

1.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

2.  Electrodialysis of lipopolysaccharides and their conversion to uniform salt forms.

Authors:  C Galanos; O Lüderitz
Journal:  Eur J Biochem       Date:  1975-06

3.  Lipopolysaccharides from Bacteroides fragilis are mitogenic for spleen cells from endotoxin responder and nonresponder mice.

Authors:  K A Joiner; K P McAdam; D L Kasper
Journal:  Infect Immun       Date:  1982-06       Impact factor: 3.441

4.  Studies on the chemical structure of the core-lipid A region of the lipopolysaccharide of Acinetobacter calcoaceticus NCTC 10305. Detection of a new 2-octulosonic acid interlinking the core oligosaccharide and lipid A component.

Authors:  K Kawahara; H Brade; E T Rietschel; U Zähringer
Journal:  Eur J Biochem       Date:  1987-03-16

5.  In vitro stimulation of C3H/HeJ spleen cells and macrophages by a lipid A precursor molecule derived from Salmonella typhimurium.

Authors:  S N Vogel; G S Madonna; L M Wahl; P D Rick
Journal:  J Immunol       Date:  1984-01       Impact factor: 5.422

6.  Functional role of interleukin 1 in periodontal disease: induction of interleukin 1 production by Bacteroides gingivalis lipopolysaccharide in peritoneal macrophages from C3H/HeN and C3H/HeJ mice.

Authors:  S Hanazawa; K Nakada; Y Ohmori; T Miyoshi; S Amano; S Kitano
Journal:  Infect Immun       Date:  1985-10       Impact factor: 3.441

7.  Immunopharmacological activities of a synthetic counterpart of a biosynthetic lipid A precursor molecule and of its analogs.

Authors:  H Takada; S Kotani; M Tsujimoto; T Ogawa; I Takahashi; K Harada; C Katsukawa; S Tanaka; T Shiba; S Kusumoto
Journal:  Infect Immun       Date:  1985-04       Impact factor: 3.441

8.  LPS regulation of the immune response: separate mechanisms for murine B cell activation by lipid A (direct) and polysaccharide (macrophage-dependent) derived from Bacteroides LPS.

Authors:  S I Williamson; M J Wannemuehler; E Jirillo; D G Pritchard; S M Michalek; J R McGhee
Journal:  J Immunol       Date:  1984-11       Impact factor: 5.422

9.  Biochemical and immunobiological properties of lipopolysaccharide (LPS) from Bacteroides gingivalis and comparison with LPS from Escherichia coli.

Authors:  T Koga; T Nishihara; T Fujiwara; T Nisizawa; N Okahashi; T Noguchi; S Hamada
Journal:  Infect Immun       Date:  1985-03       Impact factor: 3.441

10.  LPS regulation of the immune response: Bacteroides endotoxin induces mitogenic, polyclonal, and antibody responses in classical LPS responsive but not C3H/HeJ mice.

Authors:  M J Wannemuehler; S M Michalek; E Jirillo; S I Williamson; M Hirasawa; J R McGhee
Journal:  J Immunol       Date:  1984-07       Impact factor: 5.422

View more
  8 in total

1.  Monocytic cell activation by Nonendotoxic glycoprotein from Prevotella intermedia ATCC 25611 is mediated by toll-like receptor 2.

Authors:  S Sugawara; S Yang; K Iki; J Hatakeyama; R Tamai; O Takeuchi; S Akashi; T Espevik; S Akira; H Takada
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

2.  Complement-dependent accumulation and degradation of platelets in the lung and liver induced by injection of lipopolysaccharides.

Authors:  M Shibazaki; Y Kawabata; T Yokochi; A Nishida; H Takada; Y Endo
Journal:  Infect Immun       Date:  1999-10       Impact factor: 3.441

3.  Lipopolysaccharide enhances the production of vascular endothelial growth factor by human pulp cells in culture.

Authors:  K Matsushita; R Motani; T Sakuta; S Nagaoka; T Matsuyama; K Abeyama; I Maruyama; H Takada; M Torii
Journal:  Infect Immun       Date:  1999-04       Impact factor: 3.441

4.  Increase of CD26/dipeptidyl peptidase IV expression on human gingival fibroblasts upon stimulation with cytokines and bacterial components.

Authors:  E Nemoto; S Sugawara; H Takada; S Shoji; H Horiuch
Journal:  Infect Immun       Date:  1999-12       Impact factor: 3.441

5.  Human gingival CD14(+) fibroblasts primed with gamma interferon increase production of interleukin-8 in response to lipopolysaccharide through up-regulation of membrane CD14 and MyD88 mRNA expression.

Authors:  Riyoko Tamai; Tetsuya Sakuta; Kenji Matsushita; Mitsuo Torii; Osamu Takeuchi; Shizuo Akira; Sachiko Akashi; Terje Espevik; Shunji Sugawara; Haruhiko Takada
Journal:  Infect Immun       Date:  2002-03       Impact factor: 3.441

6.  Prevotella intermedia stimulates expansion of Vbeta-specific CD4(+) T cells.

Authors:  K P Leung; B A Torres
Journal:  Infect Immun       Date:  2000-09       Impact factor: 3.441

7.  Expression Profiles of TGF-β and TLR Pathways in Porphyromonas gingivalis and Prevotella intermedia Challenged Osteoblasts.

Authors:  Kubra Aydin; Fatma Yesim Ekinci; May Korachi
Journal:  Jundishapur J Microbiol       Date:  2015-04-18       Impact factor: 0.747

8.  Comparative genome analysis of Prevotella intermedia strain isolated from infected root canal reveals features related to pathogenicity and adaptation.

Authors:  Yunfeng Ruan; Lu Shen; Yan Zou; Zhengnan Qi; Jun Yin; Jie Jiang; Liang Guo; Lin He; Zijiang Chen; Zisheng Tang; Shengying Qin
Journal:  BMC Genomics       Date:  2015-02-25       Impact factor: 3.969

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.